Showing results (601-610 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|March 2, 2012
Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoproteinDeboeeta Chatterjee, Bala Chandran, Edward A BergerMabs|June 1, 2012
A high throughput capillary electrophoresis method to obtain pharmacokinetics and quality attributes of a therapeutic molecule in circulationReema Piparia, David Ouellette, W Blaine Stine, et al.Mabs|August 8, 2018
Minimal physiologically-based pharmacokinetic modeling of DSTA4637A, A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus, in a mouse modelShun Xin Wang-Lin, Chenguang Zhou, Amrita V Kamath, et al.Mabs|August 22, 2018
Multi-angle light scattering as a process analytical technology measuring real-time molecular weight for downstream process controlBhumit A Patel, Adrian Gospodarek, Michael Larkin, et al.Mabs|August 22, 2018
High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutantsDanielle M DiCara, Nisana Andersen, Ruby Chan, et al.Mabs|August 22, 2018
A minimal physiologically based pharmacokinetic model to investigate FcRn-mediated monoclonal antibody salvage: Effects of Kon, Koff, endosome trafficking, and animal speciesBrian M Maas, Yanguang CaoMabs|July 10, 2018
Comprehensive study of domain rearrangements of single-chain bispecific antibodies to determine the best combination of configurations and microbial host cellsRyutaro Asano, Yuri Kuroki, Sachiko Honma, et al.Mabs|September 20, 2018
Comprehensive characterization of monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometryYutong Jin, Ziqing Lin, Qingge Xu, et al.Mabs|September 11, 2018
MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicityNobuo Sekiguchi, Chiyomi Kubo, Ayako Takahashi, et al.Mabs|November 18, 2016
Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targetingMelissa L Geddie, Neeraj Kohli, Dmitri B Kirpotin, et al.Pageof 180